Molecular Templates, Inc. (MTEM) earnings
MTEM earnings moved a median of +1.30% by the close. Quarterly and annual MTEM reports and results, each read against the price at its own news timestamp. Back to the MTEM overview →
11 measured MTEM earnings events.
Where these MTEM earnings landedvs 11 measured MTEM earnings reactions
| Middle 50% of MTEM earnings reactions | -3.18% to +4.35% |
|---|---|
| Median reaction (to close) | +1.30% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 MTEM earnings events with a measured close landed between -3.18% and +4.35%; 64% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements | Press release | +0.00% | -2.63% | |
| Form NT 10-Q Molecular Templates, For: Sep 30 | SEC filing · Form NT | -9.20% | -12.67% | |
| Form 10-Q Molecular Templates, For: Jun 30 | SEC filing · Form 10-Q | — | +6.43% | |
| Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update | Press release | — | +6.43% | |
| Form 10-Q Molecular Templates, For: Mar 31 | SEC filing · Form 10-Q | — | +3.45% | |
| Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update | Press release | — | +3.45% | |
| Form 10-K/A Molecular Templates, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.25% | |
| Form 10-K Molecular Templates, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.72% | |
| Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update | Press release | +0.00% | -3.72% | |
| Form 10-Q Molecular Templates, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.30% | |
| Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update | Press release | +0.00% | +1.30% |
Keep exploring
More MTEM: analyst actions → · SEC filings → · MTEM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | 84 | 0.00% | 14% |
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
| PharmaCyte Biotech, Inc. (PMCB) | 84 | 0.00% | 41% |
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.